Regulation of the severity of neuroinflammation and demyelination by TLR‐ASK1‐p38 pathway

Author:

Guo Xiaoli1,Harada Chikako1,Namekata Kazuhiko1,Matsuzawa Atsushi2,Camps Monsterrat3,Ji Hong4,Swinnen Dominique5,Jorand‐Lebrun Catherine5,Muzerelle Mathilde5,Vitte Pierre‐Alain4,Rückle Thomas5,Kimura Atsuko1,Kohyama Kuniko6,Matsumoto Yoh6,Ichijo Hidenori2,Harada Takayuki1

Affiliation:

1. Department of Molecular Neurobiology, Tokyo Metropolitan Institute for Neuroscience, Tokyo Metropolitan Organization for Medical Research, Fuchu, Tokyo, Japan

2. Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences, Global Center of Excellence Program, Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, The University of Tokyo, Tokyo, Japan

3. Department of Inflammation, Merck Serono International S.A., Chemin de Mines, Geneva, Switzerland

4. Department of Early PK/PD, Merck Serono International S.A., Chemin de Mines, Geneva, Switzerland

5. Department of Chemistry, Merck Serono International S.A., Chemin de Mines, Geneva, Switzerland

6. Department of Molecular Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Tokyo Metropolitan Organization for Medical Research, Fuchu, Tokyo, Japan

Publisher

EMBO

Subject

Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3